Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood ...

Medicare covers inpatient and outpatient care for skin cancer. People with Original Medicare parts A and B or Medicare Advantage plans can expect extensive coverage, but they will likely have out ...

Most health insurance providers and Medicare cover Gentle Cure. Medicare Part A covers radiation therapy when you are receiving inpatient treatment in the hospital. Part B covers radiation therapy for ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...

Researchers utilized the comprehensive score for financial toxicity tool to measure self-reported financial distress among ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Medicare will soon negotiate prices for 15 more drugs as part of an effort to ...

Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

Medicare now covers Guardant Reveal for monitoring colorectal cancer recurrence after curative therapy. Analyst sees expanded coverage boosting revenue and improving gross margins by year-end.

This test predicts cancer recurrence ... This represents an expansion from the prior Medicare coverage of Guardant Reveal testing for CRC only in the early post-surgical setting.